Author:Jessica Jinks
Citation: Neurol AMJ. 2026; https://doi.org/10.33590/neurolamj/KK200SGN
Date correction published: 03/04/2026
Original publication¹
In the KOL interview article1 published on the AMJ website on January 22nd 2026, an error has been identified in Figure 3A.
An error has been identified in Figure 3A of the published article. The four line markers and associated values above the bars were displayed in colours that did not correspond to the figure key.
Figure 3A has been updated to ensure the colours align with the key and accurately represent the data.
AMJ apologises for the error and any inconvenience caused.
Reference:
1. Jinks J. Rethinking Early Intervention in Relapsing Multiple Sclerosis: A Closer Look at Long-Term Safety and Efficacy Data for a Sphingosine 1-Phosphate Receptor Modulator. Neurol AMJ. 2026;3[Suppl 1]:2-14.
